BioNTech SE ADR

24 de ago. de 2026, 23:26 UTC

Biontech SE shares are lower in after-market trading with no specific news identified. Broader market volatility is influenced by geopolitical developments and U.S. sanctions on Iran.

21 de ago. de 2026, 20:01 UTC

BioNTech SE shares are higher as the company prepares to present new lung cancer treatment data at the IASLC conference in 2026.

20 de ago. de 2026, 23:16 UTC

BioNTech SE shares are lower in after-market trading as it announces new clinical data for lung cancer treatment at the IASLC conference in 2026.

19 de ago. de 2026, 23:41 UTC

BioNTech SE is trading lower in after-market hours amid a decline in the Biotechnology sub-sector and concerns over neoantigen vaccines and capital strategies.

18 de ago. de 2026, 21:01 UTC

BioNTech SE shares are trading lower in after-market hours, amid cautious sentiment linked to fluctuations in sovereign bond yields.

17 de ago. de 2026, 19:56 UTC

BioNTech SE shares are lower today, reflecting broader market trends amid rising crude oil prices and inflationary pressures. The stock peaked earlier in the session.

14 de ago. de 2026, 19:26 UTC

BioNTech SE shares are higher today, continuing an upward trend since Thursday. This movement occurs despite concerns over declining U.S. retail sales data.

13 de ago. de 2026, 19:21 UTC

BioNTech SE shares are lower as analysts adjust price targets following a significant second-quarter revenue decline and a net loss of €820.8 million.

12 de ago. de 2026, 19:26 UTC

BioNTech SE's shares are higher today, supported by a significant rise in Moderna Inc. amid optimistic market sentiment following recent inflation data.

11 de ago. de 2026, 20:06 UTC

BioNTech SE shares are near unchanged amid a flat market performance. The stock remains above its 20-day moving average and near the upper end of its one-month range.

10 de ago. de 2026, 21:01 UTC

BioNTech SE shares are higher in after-market trading, showing stability despite broader market conditions and weaker-than-expected job growth data.

7 de ago. de 2026, 19:56 UTC

BioNTech SE is trading higher, likely influenced by Moderna's significant gains. The stock remains above its 20-day moving average despite recent revenue declines.

6 de ago. de 2026, 19:51 UTC

BioNTech SE shares are lower amid negative sentiment in the Biotechnology sector, following a revenue decline and CEO transition announcement.

5 de ago. de 2026, 19:32 UTC

BioNTech SE shares are higher today after Citigroup maintained its Buy rating, lowering its price target to $125 while Evercore ISI kept its Outperform rating at $130.

4 de ago. de 2026, 20:03 UTC

BioNTech SE reported a widened second-quarter loss and lowered 2026 revenue guidance, contributing to shares trading lower since Monday's close.

3 de ago. de 2026, 21:01 UTC

BioNTech SE shares are lower in after-market hours, showing little movement despite a broader market rally and investor optimism from lower oil prices.

31 de jul. de 2026, 19:16 UTC

BioNTech SE shares are lower today, pressured by broader market sentiment and a decline in Moderna Inc. The stock remains below its 20-day moving average.

30 de jul. de 2026, 21:01 UTC

BioNTech SE shares are trading lower in after-market hours, reversing earlier gains and reflecting notable volatility without any specific news to explain the movement.

29 de jul. de 2026, 19:55 UTC

BioNTech SE shares are advancing during Wednesday's session, reaching a session high earlier today before pulling back slightly. No specific news was identified.

28 de jul. de 2026, 19:16 UTC

BioNTech SE shares are advancing today, rebounding from earlier lows. The stock's resilience contrasts with declines in the Nikkei 225 Index.

27 de jul. de 2026, 19:06 UTC

BioNTech SE shares are higher today amid positive market sentiment, reaching a peak earlier. No specific news has been identified to explain the movement.

24 de jul. de 2026, 19:06 UTC

BioNTech SE shares are lower today, continuing a decline amid broader market pressure and a significant drop in crude oil prices.

22 de jul. de 2026, 18:06 UTC

BioNTech SE shares are lower today, reflecting broader market caution amid rising crude oil prices and geopolitical tensions ahead of major technology earnings reports.

21 de jul. de 2026, 14:41 UTC

BioNTech SE is rising amid positive market sentiment and plans to report second-quarter 2026 results on August 4, 2026. The Nasdaq 100 Index is also up.

20 de jul. de 2026, 19:06 UTC

BioNTech SE shares are higher today, supported by a positive analyst outlook and an average recommendation of "Moderate Buy" from nineteen brokerage firms.